Antipsychotics agents

Koppala RVS Chaitanya
Koppala RVS ChaitanyaAssociate Professor em ANDHRA UNIVERSITY
Antipsychotics
Drugs
Pharmacology
KRVS Chaitanya
Psychosis
• A symptom of mental illness
• Characterized by a distorted or non existent sense of reality
– Hallucinations
– Delusions
– Disorganized speech
– Disorganized or agitated behaviour
1. Mood disorders (major depression or mania) with
psychotic features
2. Substance induced psychosis
3. Dementia with psychotic features
4. Delirium with psychotic features
5. Schizophrenia
Dopamine hypothesis
• Put forward by Arvid Carlsson
• “The clinical features of schizophrenia (sometime extended to
psychosis in general) is related to over activity of
dopaminergic function within the brain.”
Effects of Increasing Dopamine
• Dopamine is a monoamine neurotransmitter that is synthesized
by the conversion of tyrosine to DOPA, which undergoes
decarboxylation and forms dopamine.
• The functions of dopamine depend on the pathway involved.
They include:
1. Motor control in the nigrostriatal pathway.
2. Behavioural effects in the mesolimbic and mesocortical pathways.
3. Endocrine control in the tuberoinfundibular pathway.
Dopaminergic pathways
• Dopamine has been implicated in the pathogenesis of schizophrenia
in what is known as the dopamine hypothesis or theory.
• Carlson, who was awarded a Nobel Prize in 2000, originally
proposed this theory.
• Excess levels of dopamine have been linked to psychotic
behaviours, based on pharmacological evidence and various studies
involving humans and animals.
• Amphetamines cause increased levels of dopamine in the
brain and can result in acute psychotic episodes similar to what
is seen in schizophrenia.
• Furthermore, drugs used in Parkinson’s disease, including
levodopa and dopamine agonists, can cause hallucinations as a
side effect.
• It is also known that amphetamine, as well as other drugs that
act as dopamine agonists, worsen symptoms in patients with
schizophrenia.
Antipsychotics agents
Antipsychotics agents
• Studies with brain imaging have shown that there is increased
dopamine production and release in the striatum of the brain in
schizophrenic patients.
• Furthermore, amphetamine administration in schizophrenic
patients has been found to result in greater dopamine release
compared to control subjects.
• In animal studies, increased dopamine levels lead to
stereotyped, repetitive behaviours, like that which sometimes
occurs in schizophrenia.
• Animals that are administered potent D2 receptor agonists like
bromocriptine also develop such behaviours.
• In support of such evidence, dopamine antagonists, including
antipsychotic agents, have been consistently found to be
effective in treating the positive symptoms of schizophrenia.
• In fact, antagonist activity at the dopamine receptors is the
main mechanism action of the antipsychotics in clinical use for
schizophrenic patients.
Schizophrenia pathogenesis
• In schizophrenia, there is over activity of D2 receptors in the
mesolimbic dopaminergic pathway, which causes positive
symptoms.
• In contrast, negative symptoms may be caused by decreased activity
of D1 receptors in the mesocortical dopaminergic pathway.
• There have been new findings regarding the pathogenesis of
schizophrenia.
• Aside from the role of dopamine, it is believed that glutamate under
activity may play an important part in this condition.
Psychotic Disorder Medication
• Antipsychotic drugs work chiefly by blocking postsynaptic
dopamine D2 receptors.
• Therapeutic effects are achieved when there is a blockade of at
least 80 % of the D2 receptors.
• While the blockade of dopamine receptors is an immediate
effect of drug administration, the therapeutic effect may be
delayed for up to several weeks, and the reason for this is
unknown.
• The therapeutic effects of antipsychotic drugs
include decreased dopaminergic neuronal activity and an
upregulation of dopamine receptors.
• However, an immediate effect of antipsychotics is their
sedating quality, making them useful in acute behavioural
emergencies.
• Antipsychotics are broadly divided into two categories: first-
generation antipsychotics, also known as typical
antipsychotics, and second-generation antipsychotics, called
atypical antipsychotics.
• The first-generation antipsychotic agents were introduced in
the 1950s, while atypical second-generation agents were
developed in more recent times.
Classification
1. Phenothiazines
– Aliphatic side chain: Chlorpromazine
Triflupromazine
– Piperidine side chain: Thioridazine
– Piperazine side chain: Trifluoperazine
Fluphenazine
2. Butyrophenones
• Haloperidol
• Trifluperidol
• Penfluridol
3. Thioxanthenes :
Flupenthixol
4. Other heterocyclic :
Pimozide, Loxapine
5. Atypical antipsychotics:
Clozapine Aripiprazole
Risperidone Ziprasidone
Olanzapine Amisulpiride
Quetiapine Zotepine
Classification II
A. Typical /first generation antipsychotics
1. Phenothiazines: Chlorpromazine
2. Butyrophenones: Haloperidol
3. Thioxanthenes : Flupentixol
B. Atypical/second generation antipsychotics
– E.g.: Clozapine, Risperidone, Olanzapine, Quetiapine,
Aripiprazole
• Typical and atypical antipsychotics differ in relation to their
mechanism of action, side effect profile, and clinical effect.
• Typical antipsychotics primarily bind and inhibit dopaminergic D2
receptors and treat positive symptoms.
• Atypical antipsychotics bind to D2 receptors as well as serotonergic
5-HT2a receptors.
• Atypical agents treat positive symptoms, but may also have an effect
in improving negative symptoms and cognitive impairment because
of 5-HT2a receptor antagonism.
• First generation of antipsychotics agents Predominantly act as
antagonist at brains dopamine D2 receptors also blocks
1. Muscarinic acetylcholine receptors
2. Histamine receptors
3. Alpha adrenergic receptors
Pharmacokinetics
1. High rapid oral absorption
2. High lipophilic with high apparent volumes of distribution
3. Undergo extensive phase 1 metabolism by CYPs and
subsequent phase 2 conjugations
4. Excreted in urine and to some extent in the bile.
Antipsychotics agents
• One of the key differences between typical and atypical
antipsychotic drugs is that the newer atypical agents have a
lower incidence of Extrapyramidal motor side effects.
• This is because the newer agents have activity at other
receptors.
• Other reasons for reduced Extrapyramidal effects may include
the fact that some of these drugs dissociate rapidly from the
dopamine receptor, while others act as partial agonists.
Examples of typical and atypical antipsychotics
Typical (first generation) Atypical (second generation)
Chlorpromazine
Clopentixol
Flupentixol
Fluphenazine
Haloperidol
Amisulpride
Aripiprazole
Clozapine
Quetiapine
Risperidone
Sertindole
Ziprasidone
Zotepine
Side Effects of Antipsychotics
1. Extrapyramidal motor side effects
– Motor disturbances are the result of direct or
indirect blockade of D2 receptors in the nigrostriatal
dopaminergic pathway.
– The first-generation antipsychotic drugs are traditionally
associated with a greater incidence of motor disturbances.
– However, even the atypical antipsychotics can cause
Extrapyramidal effects, including olanzapine, quetiapine,
and risperidone.
Extrapyramidal symptoms:
1. Acute dystonia
2. Akathisia
3. Parkinsonism
4. Tardive dyskinesia
2. Cardiac effects
– Antipsychotics use may cause a prolonged QT interval, which
can lead to ventricular arrhythmias and sudden cardiac death.
3. Endocrine effects
– Blockade of dopamine receptors in the tuberoinfundibular
pathway results in increased prolactin secretion, as one of the
functions of dopamine is to suppress prolactin.
– Hyperprolactinemia can lead to menstrual irregularities, breast
enlargement, and galactorrhea.
4. Anti-muscarinic effects
– Blockade of muscarinic cholinergic receptors may cause effects such
as dry mouth and eyes, blurred vision, increased intraocular
pressure, urinary retention, constipation, and confusion.
5. Anti-adrenergic effects
– The blockade of adrenergic receptors can result in orthostatic
hypotension and reflex tachycardia.
6. Anti-histamine effects
– The blockade of histamine receptors can result in sedation.
– This is an effect of certain phenothiazine antipsychotics such as
chlorpromazine.
7. Metabolic and cardiovascular side effects
– This group of side effects is very important to consider.
– Antipsychotics can cause weight gain, diabetes mellitus, and
cardiovascular disease.
– These side effects are more common with the second-generation
atypical antipsychotics, such as olanzapine, clozapine, and quetiapine.
8. Sexual dysfunction
– Decreased libido and erectile dysfunction may occur in men.
– Those conditions are a result of a combination of dopamine,
adrenergic and muscarinic receptor blockade.
9. Other side effects
– Include allergic reactions (e.g., urticaria), idiosyncratic reactions
such as obstructive jaundice (with phenothiazines), leukopenia
and agranulocytosis (higher incidence with clozapine).
10. Neuroleptic malignant syndrome
• A rare syndrome occurring in 1—2 % of patients.
• It is characterized by hyperthermia, muscle rigidity, mental
confusion, and autonomic nervous system dysfunction.
• This syndrome is fatal in 10—20 % of the cases as it can
cause renal or cardiovascular failure.
• Treatment is by the immediate cessation of the antipsychotic
drug and administration of bromocriptine, a dopamine
receptor agonist, and dantrolene, a skeletal muscle relaxant.
Antipsychotics agents
Bipolar Disorder Medication
Drugs used in the treatment of bipolar disorder include:
1. Lithium
2. Anti-epileptic drugs
3. Atypical antipsychotic drugs
4. Antidepressants (for bipolar depression)
5. Other drugs, including benzodiazepine, memantine,
amantadine, and ketamine.
Mood Stabilizers
• Lithium or an antiepileptic drug is typically used as a mood
stabilizer for the long-term treatment of bipolar disorder.
• They act prophylactically to prevent mood swings and
therefore reduce manic and depressive episodes.
Lithium:
• Lithium is used for the prophylactic treatment of bipolar disorder as
a mood stabilizer and in the treatment of acute mania.
• The mechanism of action of lithium is poorly understood.
• It may act by interfering with the formation of inositol triphosphate
and inhibiting kinases.
• Lithium has a narrow therapeutic range, between 0.5—1 mmol /L.
• At levels above 1.5 mmol /L, it becomes toxic.
Toxic effects of lithium include:
1. Gastrointestinal Disturbances Such As Nausea And Vomiting
2. Tremor
3. Nephrogenic Diabetes Insipidus
4. Renal Failure
5. Thyroid Enlargement
6. Hypothyroidism
7. Weight Gain
8. Hair Loss
9. Mild Cognitive Impairment
10. Acute toxicity can cause significant neurological effects,
including confusion, motor impairment, seizures, coma, and
death.
Antipsychotics agents
Antiepileptic Drugs
• Certain antiepileptic drugs may also be used as a mood stabilizer in
the treatment of bipolar disorder.
• These include carbamazepine, lamotrigine, and sodium
valproate.
• They are clinically effective and have a better side effect profile than
lithium.
• The action of antiepileptic drugs in controlling bipolar disorder may
be related to their anticonvulsant activity and blockade of sodium
channels.
• There are some differences between the antiepileptic drugs
used for bipolar disorder.
• Carbamazepine and valproate can be used for the treatment of
acute mania.
• Both valproate and lamotrigine are effective for the long-term
treatment of bipolar disorder, whereas carbamazepine is less
effective in treating bipolar depression.
Atypical Antipsychotics
• Atypical antipsychotic drugs such as olanzapine and
risperidone have a role to play in treating bipolar disorder.
• Their main mechanism of action is a blockade of D2 receptors
as well as 5HT-2 receptors.
• All atypical antipsychotics can treat mania. Some may also be
effective in treating bipolar depression.
Antidepressants
• Antidepressants are to be used with caution in patients
with bipolar disorder as they may induce or exacerbate
mania.
• They may be administered in conjunction with a mood
stabilizer.
Clinical Uses of Antipsychotics
Antipsychotics are used in the treatment of:
1. Schizophrenia
2. Bipolar Disorder
3. Schizoaffective Disorder
4. Gilles De La Tourette’s Syndrome
5. Severe Anxiety (Short Term)
6. Pain And Restlessness For Palliative Care
• Antipsychotics are conventionally used for the management of
schizophrenia.
• Schizophrenia is a psychotic disorder that affects 1 % of the
population, making it the most common psychotic disorder.
• It causes positive symptoms, such as delusions, hallucinations and
thought disorder, and negative symptoms, including social
withdrawal and a flattened affect.
• Longer-acting depot formulations of antipsychotic drugs are also
available and may be used in cases of patient preference or if
compliance is a problem.
• It should be noted that not all patients with schizophrenia respond to
therapy with antipsychotic agents.
• In patients who are resistant to two or more different antipsychotic agents,
clozapine is recommended, given its potency.
• However, because of its potentially dangerous side effects, including
leukopenia, agranulocytosis, and Myocarditis, it is usually reserved for
resistant cases.
• It requires close monitoring when used, with weekly blood tests in the first
6 months of use.
• About 30 % of patients have treatment-resistant schizophrenia, which
means that they are resistant to all available antipsychotics.
Antipsychotics agents
Drug-Induced Dyskinesia
Motor side effect Description Management
Acute dystonia Spasms of the facial or neck
muscles. Occurs within the first
few weeks of commencing an
antipsychotic drug. Generally
decreases over time.
Improves when the
drug is ceased.
May be treated with
an anticholinergic.
Akathisia Psychomotor restlessness. Improves when the
drug is ceased.
May be treated with
an anticholinergic.
Parkinsonianism Bradykinesia, tremor,
rigidity and shuffling gait.
Improves when the
drug is ceased.
May be treated with an
anticholinergic.
Tardive
dyskinesia
A serious and potentially
disabling condition.
Involuntary movements of
the face, tongue, trunk, and
limbs. This occurs after
months or years of starting
a first-generation
antipsychotic drug,
affecting 20—40 % of
patients. More common in
patients over the age of 50.
It does not improve
when the drug is
ceased. Usually
irreversible.
Antipsychotics agents
Antipsychotics agents
Antipsychotics agents
Thank you
1 de 52

Recomendados

Antipsychotic agents por
Antipsychotic agentsAntipsychotic agents
Antipsychotic agentsSteve Wilkins
1.5K visualizações154 slides
anti-psychotic drugs por
anti-psychotic drugsanti-psychotic drugs
anti-psychotic drugsDJ CrissCross
24.1K visualizações46 slides
Antipsychotics por
AntipsychoticsAntipsychotics
AntipsychoticsNaser Tadvi
56.6K visualizações30 slides
Anti psychotic drugs por
Anti psychotic drugsAnti psychotic drugs
Anti psychotic drugsDrShrey Bhatia
929 visualizações17 slides
Pharmacotherapy of antipsychotics por
Pharmacotherapy of antipsychoticsPharmacotherapy of antipsychotics
Pharmacotherapy of antipsychoticsNovo Nordisk India
1.9K visualizações62 slides
Antipsychotic drugs por
Antipsychotic drugsAntipsychotic drugs
Antipsychotic drugsFadzlina Zabri
4.6K visualizações31 slides

Mais conteúdo relacionado

Mais procurados

Antidepressants por
AntidepressantsAntidepressants
AntidepressantsSubramani Parasuraman
50.5K visualizações29 slides
Anti-Parkinsonism drugs Pharmacology por
Anti-Parkinsonism drugs PharmacologyAnti-Parkinsonism drugs Pharmacology
Anti-Parkinsonism drugs PharmacologyKoppala RVS Chaitanya
2.4K visualizações54 slides
Antidepressant drugs por
Antidepressant drugsAntidepressant drugs
Antidepressant drugsAmira Badr
18.1K visualizações62 slides
Atypical antipsychotics por
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychoticsKarrar Husain
13.9K visualizações86 slides
Antipsychotics por
AntipsychoticsAntipsychotics
AntipsychoticsChetan Rastogi
6.5K visualizações39 slides
Antipsychotics por
AntipsychoticsAntipsychotics
Antipsychoticsraj kumar
26.4K visualizações55 slides

Mais procurados(20)

Anti-Parkinsonism drugs Pharmacology por Koppala RVS Chaitanya
Anti-Parkinsonism drugs PharmacologyAnti-Parkinsonism drugs Pharmacology
Anti-Parkinsonism drugs Pharmacology
Koppala RVS Chaitanya2.4K visualizações
Antidepressant drugs por Amira Badr
Antidepressant drugsAntidepressant drugs
Antidepressant drugs
Amira Badr18.1K visualizações
Atypical antipsychotics por Karrar Husain
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychotics
Karrar Husain13.9K visualizações
Antipsychotics por Chetan Rastogi
AntipsychoticsAntipsychotics
Antipsychotics
Chetan Rastogi6.5K visualizações
Antipsychotics por raj kumar
AntipsychoticsAntipsychotics
Antipsychotics
raj kumar26.4K visualizações
Class antiparkinsonian drugs por Raghu Prasada
Class antiparkinsonian drugsClass antiparkinsonian drugs
Class antiparkinsonian drugs
Raghu Prasada13K visualizações
Antidepressants - Pharmacology por Areej Abu Hanieh
 Antidepressants - Pharmacology Antidepressants - Pharmacology
Antidepressants - Pharmacology
Areej Abu Hanieh76.4K visualizações
Typical antipsychotics por Anant Rathi
Typical   antipsychoticsTypical   antipsychotics
Typical antipsychotics
Anant Rathi7.8K visualizações
Pharmacotherapy of schizophrenia por Prasheeta V P
Pharmacotherapy of schizophreniaPharmacotherapy of schizophrenia
Pharmacotherapy of schizophrenia
Prasheeta V P3.9K visualizações
Antipsychotic drug por Vibha Manu
Antipsychotic drug Antipsychotic drug
Antipsychotic drug
Vibha Manu8.5K visualizações
ANTI ANXIETY AGENTS / DRUGS USED IN THE TREATMENT OF ANXIETY por Kameshwaran Sugavanam
ANTI ANXIETY AGENTS / DRUGS USED IN THE TREATMENT OF ANXIETYANTI ANXIETY AGENTS / DRUGS USED IN THE TREATMENT OF ANXIETY
ANTI ANXIETY AGENTS / DRUGS USED IN THE TREATMENT OF ANXIETY
Kameshwaran Sugavanam527 visualizações
Antipsychotics - Pharmacology por Areej Abu Hanieh
Antipsychotics - PharmacologyAntipsychotics - Pharmacology
Antipsychotics - Pharmacology
Areej Abu Hanieh24.4K visualizações
Schizophrenia and Antipsychotic Drugs por FarazaJaved
Schizophrenia and Antipsychotic DrugsSchizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic Drugs
FarazaJaved15.3K visualizações
Atypical antipsychotics por Murugavel Veeramani
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychotics
Murugavel Veeramani5.7K visualizações
Anti parkinsonian drugs por Dr. Mohit Kulmi
Anti parkinsonian drugsAnti parkinsonian drugs
Anti parkinsonian drugs
Dr. Mohit Kulmi58.8K visualizações
Antipsychotic drugs por Subramani Parasuraman
Antipsychotic drugsAntipsychotic drugs
Antipsychotic drugs
Subramani Parasuraman307.9K visualizações
Drug Therapy of Depression por Dr Htet
Drug Therapy of Depression Drug Therapy of Depression
Drug Therapy of Depression
Dr Htet7.1K visualizações

Similar a Antipsychotics agents

Pharmacology I, Antipsychotic (Neuroleptic) Drugs NK-Trimmed.pptx por
Pharmacology I, Antipsychotic (Neuroleptic) Drugs NK-Trimmed.pptxPharmacology I, Antipsychotic (Neuroleptic) Drugs NK-Trimmed.pptx
Pharmacology I, Antipsychotic (Neuroleptic) Drugs NK-Trimmed.pptxAhmad Kharousheh
21 visualizações34 slides
Shizophrenia por
ShizophreniaShizophrenia
ShizophreniaZainab&Sons
73 visualizações30 slides
Shizophrenia por
ShizophreniaShizophrenia
ShizophreniaZainab&Sons
127 visualizações30 slides
SCHIZ AND ANTIPSYCHOTICS.pptx por
SCHIZ AND ANTIPSYCHOTICS.pptxSCHIZ AND ANTIPSYCHOTICS.pptx
SCHIZ AND ANTIPSYCHOTICS.pptxSWATI SINGH
25 visualizações10 slides
antipsycotic drug.pptx por
antipsycotic drug.pptxantipsycotic drug.pptx
antipsycotic drug.pptxDuckzsengalDuckzseng
18 visualizações12 slides
Anti P por
Anti PAnti P
Anti PFlavio Guzmán
1.4K visualizações23 slides

Similar a Antipsychotics agents (20)

Pharmacology I, Antipsychotic (Neuroleptic) Drugs NK-Trimmed.pptx por Ahmad Kharousheh
Pharmacology I, Antipsychotic (Neuroleptic) Drugs NK-Trimmed.pptxPharmacology I, Antipsychotic (Neuroleptic) Drugs NK-Trimmed.pptx
Pharmacology I, Antipsychotic (Neuroleptic) Drugs NK-Trimmed.pptx
Ahmad Kharousheh21 visualizações
Shizophrenia por Zainab&Sons
ShizophreniaShizophrenia
Shizophrenia
Zainab&Sons73 visualizações
Shizophrenia por Zainab&Sons
ShizophreniaShizophrenia
Shizophrenia
Zainab&Sons127 visualizações
SCHIZ AND ANTIPSYCHOTICS.pptx por SWATI SINGH
SCHIZ AND ANTIPSYCHOTICS.pptxSCHIZ AND ANTIPSYCHOTICS.pptx
SCHIZ AND ANTIPSYCHOTICS.pptx
SWATI SINGH25 visualizações
Anti P por Flavio Guzmán
Anti PAnti P
Anti P
Flavio Guzmán1.4K visualizações
JJ Antipsychotics.pptx por InderjitKaur91
JJ Antipsychotics.pptxJJ Antipsychotics.pptx
JJ Antipsychotics.pptx
InderjitKaur9138 visualizações
Psychopharmacology.pptx por Eric808667
Psychopharmacology.pptxPsychopharmacology.pptx
Psychopharmacology.pptx
Eric80866721 visualizações
Antipsychotics por Dr. Marya Ahsan
AntipsychoticsAntipsychotics
Antipsychotics
Dr. Marya Ahsan161 visualizações
Antipsychotics por Mamona Waheed
AntipsychoticsAntipsychotics
Antipsychotics
Mamona Waheed6.7K visualizações
3- Antipsychotic agents.ppt por AshlynnElla3
3- Antipsychotic agents.ppt3- Antipsychotic agents.ppt
3- Antipsychotic agents.ppt
AshlynnElla311 visualizações
Antipsychotics por Mbi Gerald Mbi
AntipsychoticsAntipsychotics
Antipsychotics
Mbi Gerald Mbi1K visualizações
Treatment of psychosis por Dr. Vijay Prasad
Treatment of psychosisTreatment of psychosis
Treatment of psychosis
Dr. Vijay Prasad5.6K visualizações
Antidepressants screening models por Mohd Riyaz Beg
Antidepressants screening modelsAntidepressants screening models
Antidepressants screening models
Mohd Riyaz Beg167 visualizações
Neuroleptics (antipsychotics) por Mohsin Aziz
Neuroleptics (antipsychotics)Neuroleptics (antipsychotics)
Neuroleptics (antipsychotics)
Mohsin Aziz17.7K visualizações

Mais de Koppala RVS Chaitanya

THYROID HORMONES AND THYROID INHIBITORS.pdf por
THYROID HORMONES AND THYROID INHIBITORS.pdfTHYROID HORMONES AND THYROID INHIBITORS.pdf
THYROID HORMONES AND THYROID INHIBITORS.pdfKoppala RVS Chaitanya
5 visualizações7 slides
CORTICOSTERIODS.pdf por
CORTICOSTERIODS.pdfCORTICOSTERIODS.pdf
CORTICOSTERIODS.pdfKoppala RVS Chaitanya
6 visualizações6 slides
Anterior Pituitary Hormones.pdf por
Anterior Pituitary Hormones.pdfAnterior Pituitary Hormones.pdf
Anterior Pituitary Hormones.pdfKoppala RVS Chaitanya
11 visualizações6 slides
Anti gout drugs.pdf por
Anti gout drugs.pdfAnti gout drugs.pdf
Anti gout drugs.pdfKoppala RVS Chaitanya
19 visualizações6 slides
Anti Rheumatic drugs.pdf por
Anti Rheumatic drugs.pdfAnti Rheumatic drugs.pdf
Anti Rheumatic drugs.pdfKoppala RVS Chaitanya
21 visualizações5 slides
Non Steroidal Anti inflammatory Drugs.pdf por
Non Steroidal Anti inflammatory Drugs.pdfNon Steroidal Anti inflammatory Drugs.pdf
Non Steroidal Anti inflammatory Drugs.pdfKoppala RVS Chaitanya
9 visualizações13 slides

Mais de Koppala RVS Chaitanya(20)

THYROID HORMONES AND THYROID INHIBITORS.pdf por Koppala RVS Chaitanya
THYROID HORMONES AND THYROID INHIBITORS.pdfTHYROID HORMONES AND THYROID INHIBITORS.pdf
THYROID HORMONES AND THYROID INHIBITORS.pdf
Koppala RVS Chaitanya5 visualizações
Anterior Pituitary Hormones.pdf por Koppala RVS Chaitanya
Anterior Pituitary Hormones.pdfAnterior Pituitary Hormones.pdf
Anterior Pituitary Hormones.pdf
Koppala RVS Chaitanya11 visualizações
Non Steroidal Anti inflammatory Drugs.pdf por Koppala RVS Chaitanya
Non Steroidal Anti inflammatory Drugs.pdfNon Steroidal Anti inflammatory Drugs.pdf
Non Steroidal Anti inflammatory Drugs.pdf
Koppala RVS Chaitanya9 visualizações
Antiplatelet drugs pharmacology.pdf por Koppala RVS Chaitanya
Antiplatelet drugs pharmacology.pdfAntiplatelet drugs pharmacology.pdf
Antiplatelet drugs pharmacology.pdf
Koppala RVS Chaitanya181 visualizações
Barbiturate Poisoning.pdf por Koppala RVS Chaitanya
Barbiturate Poisoning.pdfBarbiturate Poisoning.pdf
Barbiturate Poisoning.pdf
Koppala RVS Chaitanya1.7K visualizações
Organophosphorous Poisoning.pdf por Koppala RVS Chaitanya
Organophosphorous Poisoning.pdfOrganophosphorous Poisoning.pdf
Organophosphorous Poisoning.pdf
Koppala RVS Chaitanya314 visualizações
PARACETAMOL PHARMACOLOGY por Koppala RVS Chaitanya
PARACETAMOL PHARMACOLOGYPARACETAMOL PHARMACOLOGY
PARACETAMOL PHARMACOLOGY
Koppala RVS Chaitanya19.3K visualizações

Último

Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends por
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness TrendsTop Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trendsmuskansbl01
59 visualizações15 slides
The Art of naming drugs.pptx por
The Art of naming drugs.pptxThe Art of naming drugs.pptx
The Art of naming drugs.pptxDanaKarem1
25 visualizações48 slides
BODY COMPOSITION.pptx por
BODY COMPOSITION.pptxBODY COMPOSITION.pptx
BODY COMPOSITION.pptxAneriPatwari
50 visualizações46 slides
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP por
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPMohamadAlhes
89 visualizações28 slides
CCSN Webinar - EAOCRC FINAL [Autosaved].pptx por
CCSN Webinar - EAOCRC FINAL [Autosaved].pptxCCSN Webinar - EAOCRC FINAL [Autosaved].pptx
CCSN Webinar - EAOCRC FINAL [Autosaved].pptxCanadian Cancer Survivor Network
10 visualizações36 slides
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler) por
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler) Asthalin Inhaler (Generic Albuterol Sulfate Inhaler)
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler) The Swiss Pharmacy
16 visualizações20 slides

Último(20)

Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends por muskansbl01
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness TrendsTop Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
muskansbl0159 visualizações
The Art of naming drugs.pptx por DanaKarem1
The Art of naming drugs.pptxThe Art of naming drugs.pptx
The Art of naming drugs.pptx
DanaKarem125 visualizações
BODY COMPOSITION.pptx por AneriPatwari
BODY COMPOSITION.pptxBODY COMPOSITION.pptx
BODY COMPOSITION.pptx
AneriPatwari50 visualizações
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP por MohamadAlhes
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
MohamadAlhes89 visualizações
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler) por The Swiss Pharmacy
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler) Asthalin Inhaler (Generic Albuterol Sulfate Inhaler)
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler)
The Swiss Pharmacy16 visualizações
Children with Disabilities and Environmental Factors por Olaf Kraus de Camargo
Children with Disabilities and Environmental FactorsChildren with Disabilities and Environmental Factors
Children with Disabilities and Environmental Factors
Olaf Kraus de Camargo32 visualizações
Epilepsy and Anti epileptic drugs .pdf por A. Gowtham Sashtha
Epilepsy and Anti epileptic drugs .pdfEpilepsy and Anti epileptic drugs .pdf
Epilepsy and Anti epileptic drugs .pdf
A. Gowtham Sashtha20 visualizações
Buccoadhesive drug delivery System.pptx por ABG
Buccoadhesive drug delivery System.pptxBuccoadhesive drug delivery System.pptx
Buccoadhesive drug delivery System.pptx
ABG167 visualizações
eTEP -RS Dr.TVR.pptx por Varunraju9
eTEP -RS Dr.TVR.pptxeTEP -RS Dr.TVR.pptx
eTEP -RS Dr.TVR.pptx
Varunraju9148 visualizações
Looking For Exceptional Dental Care In Simi Valley We’ve Got The Answer por Dental Group of Simi Valley
Looking For Exceptional Dental Care In Simi Valley We’ve Got The AnswerLooking For Exceptional Dental Care In Simi Valley We’ve Got The Answer
Looking For Exceptional Dental Care In Simi Valley We’ve Got The Answer
Dental Group of Simi Valley26 visualizações
HYPERTENSION.pptx por Yogesh684750
HYPERTENSION.pptxHYPERTENSION.pptx
HYPERTENSION.pptx
Yogesh68475029 visualizações
MAINTAINING A HEALTHY LIFE.doc por Dr. MWEBAZA VICTOR
MAINTAINING A HEALTHY LIFE.docMAINTAINING A HEALTHY LIFE.doc
MAINTAINING A HEALTHY LIFE.doc
Dr. MWEBAZA VICTOR 64 visualizações
Scrotal and Testicular Swelling.pptx por Michael Sintayehu
Scrotal and Testicular Swelling.pptxScrotal and Testicular Swelling.pptx
Scrotal and Testicular Swelling.pptx
Michael Sintayehu23 visualizações
Calcutta Clinical Course - Allen College of Homoeopathy por Allen College
Calcutta Clinical Course - Allen College of HomoeopathyCalcutta Clinical Course - Allen College of Homoeopathy
Calcutta Clinical Course - Allen College of Homoeopathy
Allen College94 visualizações
vitamin c.pptx por ajithkilpart
vitamin c.pptxvitamin c.pptx
vitamin c.pptx
ajithkilpart19 visualizações
Explore new Frontiers in Medicine with AI.pdf por Anne Marie
Explore new Frontiers in Medicine with AI.pdfExplore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdf
Anne Marie18 visualizações

Antipsychotics agents

  • 2. Psychosis • A symptom of mental illness • Characterized by a distorted or non existent sense of reality – Hallucinations – Delusions – Disorganized speech – Disorganized or agitated behaviour
  • 3. 1. Mood disorders (major depression or mania) with psychotic features 2. Substance induced psychosis 3. Dementia with psychotic features 4. Delirium with psychotic features 5. Schizophrenia
  • 4. Dopamine hypothesis • Put forward by Arvid Carlsson • “The clinical features of schizophrenia (sometime extended to psychosis in general) is related to over activity of dopaminergic function within the brain.”
  • 5. Effects of Increasing Dopamine • Dopamine is a monoamine neurotransmitter that is synthesized by the conversion of tyrosine to DOPA, which undergoes decarboxylation and forms dopamine. • The functions of dopamine depend on the pathway involved. They include: 1. Motor control in the nigrostriatal pathway. 2. Behavioural effects in the mesolimbic and mesocortical pathways. 3. Endocrine control in the tuberoinfundibular pathway.
  • 6. Dopaminergic pathways • Dopamine has been implicated in the pathogenesis of schizophrenia in what is known as the dopamine hypothesis or theory. • Carlson, who was awarded a Nobel Prize in 2000, originally proposed this theory. • Excess levels of dopamine have been linked to psychotic behaviours, based on pharmacological evidence and various studies involving humans and animals.
  • 7. • Amphetamines cause increased levels of dopamine in the brain and can result in acute psychotic episodes similar to what is seen in schizophrenia. • Furthermore, drugs used in Parkinson’s disease, including levodopa and dopamine agonists, can cause hallucinations as a side effect. • It is also known that amphetamine, as well as other drugs that act as dopamine agonists, worsen symptoms in patients with schizophrenia.
  • 10. • Studies with brain imaging have shown that there is increased dopamine production and release in the striatum of the brain in schizophrenic patients. • Furthermore, amphetamine administration in schizophrenic patients has been found to result in greater dopamine release compared to control subjects.
  • 11. • In animal studies, increased dopamine levels lead to stereotyped, repetitive behaviours, like that which sometimes occurs in schizophrenia. • Animals that are administered potent D2 receptor agonists like bromocriptine also develop such behaviours.
  • 12. • In support of such evidence, dopamine antagonists, including antipsychotic agents, have been consistently found to be effective in treating the positive symptoms of schizophrenia. • In fact, antagonist activity at the dopamine receptors is the main mechanism action of the antipsychotics in clinical use for schizophrenic patients.
  • 13. Schizophrenia pathogenesis • In schizophrenia, there is over activity of D2 receptors in the mesolimbic dopaminergic pathway, which causes positive symptoms. • In contrast, negative symptoms may be caused by decreased activity of D1 receptors in the mesocortical dopaminergic pathway. • There have been new findings regarding the pathogenesis of schizophrenia. • Aside from the role of dopamine, it is believed that glutamate under activity may play an important part in this condition.
  • 14. Psychotic Disorder Medication • Antipsychotic drugs work chiefly by blocking postsynaptic dopamine D2 receptors. • Therapeutic effects are achieved when there is a blockade of at least 80 % of the D2 receptors. • While the blockade of dopamine receptors is an immediate effect of drug administration, the therapeutic effect may be delayed for up to several weeks, and the reason for this is unknown.
  • 15. • The therapeutic effects of antipsychotic drugs include decreased dopaminergic neuronal activity and an upregulation of dopamine receptors. • However, an immediate effect of antipsychotics is their sedating quality, making them useful in acute behavioural emergencies.
  • 16. • Antipsychotics are broadly divided into two categories: first- generation antipsychotics, also known as typical antipsychotics, and second-generation antipsychotics, called atypical antipsychotics. • The first-generation antipsychotic agents were introduced in the 1950s, while atypical second-generation agents were developed in more recent times.
  • 17. Classification 1. Phenothiazines – Aliphatic side chain: Chlorpromazine Triflupromazine – Piperidine side chain: Thioridazine – Piperazine side chain: Trifluoperazine Fluphenazine 2. Butyrophenones • Haloperidol • Trifluperidol • Penfluridol
  • 18. 3. Thioxanthenes : Flupenthixol 4. Other heterocyclic : Pimozide, Loxapine 5. Atypical antipsychotics: Clozapine Aripiprazole Risperidone Ziprasidone Olanzapine Amisulpiride Quetiapine Zotepine
  • 19. Classification II A. Typical /first generation antipsychotics 1. Phenothiazines: Chlorpromazine 2. Butyrophenones: Haloperidol 3. Thioxanthenes : Flupentixol B. Atypical/second generation antipsychotics – E.g.: Clozapine, Risperidone, Olanzapine, Quetiapine, Aripiprazole
  • 20. • Typical and atypical antipsychotics differ in relation to their mechanism of action, side effect profile, and clinical effect. • Typical antipsychotics primarily bind and inhibit dopaminergic D2 receptors and treat positive symptoms. • Atypical antipsychotics bind to D2 receptors as well as serotonergic 5-HT2a receptors. • Atypical agents treat positive symptoms, but may also have an effect in improving negative symptoms and cognitive impairment because of 5-HT2a receptor antagonism.
  • 21. • First generation of antipsychotics agents Predominantly act as antagonist at brains dopamine D2 receptors also blocks 1. Muscarinic acetylcholine receptors 2. Histamine receptors 3. Alpha adrenergic receptors
  • 22. Pharmacokinetics 1. High rapid oral absorption 2. High lipophilic with high apparent volumes of distribution 3. Undergo extensive phase 1 metabolism by CYPs and subsequent phase 2 conjugations 4. Excreted in urine and to some extent in the bile.
  • 24. • One of the key differences between typical and atypical antipsychotic drugs is that the newer atypical agents have a lower incidence of Extrapyramidal motor side effects. • This is because the newer agents have activity at other receptors. • Other reasons for reduced Extrapyramidal effects may include the fact that some of these drugs dissociate rapidly from the dopamine receptor, while others act as partial agonists.
  • 25. Examples of typical and atypical antipsychotics Typical (first generation) Atypical (second generation) Chlorpromazine Clopentixol Flupentixol Fluphenazine Haloperidol Amisulpride Aripiprazole Clozapine Quetiapine Risperidone Sertindole Ziprasidone Zotepine
  • 26. Side Effects of Antipsychotics 1. Extrapyramidal motor side effects – Motor disturbances are the result of direct or indirect blockade of D2 receptors in the nigrostriatal dopaminergic pathway. – The first-generation antipsychotic drugs are traditionally associated with a greater incidence of motor disturbances. – However, even the atypical antipsychotics can cause Extrapyramidal effects, including olanzapine, quetiapine, and risperidone.
  • 27. Extrapyramidal symptoms: 1. Acute dystonia 2. Akathisia 3. Parkinsonism 4. Tardive dyskinesia
  • 28. 2. Cardiac effects – Antipsychotics use may cause a prolonged QT interval, which can lead to ventricular arrhythmias and sudden cardiac death. 3. Endocrine effects – Blockade of dopamine receptors in the tuberoinfundibular pathway results in increased prolactin secretion, as one of the functions of dopamine is to suppress prolactin. – Hyperprolactinemia can lead to menstrual irregularities, breast enlargement, and galactorrhea.
  • 29. 4. Anti-muscarinic effects – Blockade of muscarinic cholinergic receptors may cause effects such as dry mouth and eyes, blurred vision, increased intraocular pressure, urinary retention, constipation, and confusion. 5. Anti-adrenergic effects – The blockade of adrenergic receptors can result in orthostatic hypotension and reflex tachycardia.
  • 30. 6. Anti-histamine effects – The blockade of histamine receptors can result in sedation. – This is an effect of certain phenothiazine antipsychotics such as chlorpromazine. 7. Metabolic and cardiovascular side effects – This group of side effects is very important to consider. – Antipsychotics can cause weight gain, diabetes mellitus, and cardiovascular disease. – These side effects are more common with the second-generation atypical antipsychotics, such as olanzapine, clozapine, and quetiapine.
  • 31. 8. Sexual dysfunction – Decreased libido and erectile dysfunction may occur in men. – Those conditions are a result of a combination of dopamine, adrenergic and muscarinic receptor blockade. 9. Other side effects – Include allergic reactions (e.g., urticaria), idiosyncratic reactions such as obstructive jaundice (with phenothiazines), leukopenia and agranulocytosis (higher incidence with clozapine).
  • 32. 10. Neuroleptic malignant syndrome • A rare syndrome occurring in 1—2 % of patients. • It is characterized by hyperthermia, muscle rigidity, mental confusion, and autonomic nervous system dysfunction. • This syndrome is fatal in 10—20 % of the cases as it can cause renal or cardiovascular failure. • Treatment is by the immediate cessation of the antipsychotic drug and administration of bromocriptine, a dopamine receptor agonist, and dantrolene, a skeletal muscle relaxant.
  • 34. Bipolar Disorder Medication Drugs used in the treatment of bipolar disorder include: 1. Lithium 2. Anti-epileptic drugs 3. Atypical antipsychotic drugs 4. Antidepressants (for bipolar depression) 5. Other drugs, including benzodiazepine, memantine, amantadine, and ketamine.
  • 35. Mood Stabilizers • Lithium or an antiepileptic drug is typically used as a mood stabilizer for the long-term treatment of bipolar disorder. • They act prophylactically to prevent mood swings and therefore reduce manic and depressive episodes.
  • 36. Lithium: • Lithium is used for the prophylactic treatment of bipolar disorder as a mood stabilizer and in the treatment of acute mania. • The mechanism of action of lithium is poorly understood. • It may act by interfering with the formation of inositol triphosphate and inhibiting kinases. • Lithium has a narrow therapeutic range, between 0.5—1 mmol /L. • At levels above 1.5 mmol /L, it becomes toxic.
  • 37. Toxic effects of lithium include: 1. Gastrointestinal Disturbances Such As Nausea And Vomiting 2. Tremor 3. Nephrogenic Diabetes Insipidus 4. Renal Failure 5. Thyroid Enlargement 6. Hypothyroidism 7. Weight Gain 8. Hair Loss 9. Mild Cognitive Impairment 10. Acute toxicity can cause significant neurological effects, including confusion, motor impairment, seizures, coma, and death.
  • 39. Antiepileptic Drugs • Certain antiepileptic drugs may also be used as a mood stabilizer in the treatment of bipolar disorder. • These include carbamazepine, lamotrigine, and sodium valproate. • They are clinically effective and have a better side effect profile than lithium. • The action of antiepileptic drugs in controlling bipolar disorder may be related to their anticonvulsant activity and blockade of sodium channels.
  • 40. • There are some differences between the antiepileptic drugs used for bipolar disorder. • Carbamazepine and valproate can be used for the treatment of acute mania. • Both valproate and lamotrigine are effective for the long-term treatment of bipolar disorder, whereas carbamazepine is less effective in treating bipolar depression.
  • 41. Atypical Antipsychotics • Atypical antipsychotic drugs such as olanzapine and risperidone have a role to play in treating bipolar disorder. • Their main mechanism of action is a blockade of D2 receptors as well as 5HT-2 receptors. • All atypical antipsychotics can treat mania. Some may also be effective in treating bipolar depression.
  • 42. Antidepressants • Antidepressants are to be used with caution in patients with bipolar disorder as they may induce or exacerbate mania. • They may be administered in conjunction with a mood stabilizer.
  • 43. Clinical Uses of Antipsychotics Antipsychotics are used in the treatment of: 1. Schizophrenia 2. Bipolar Disorder 3. Schizoaffective Disorder 4. Gilles De La Tourette’s Syndrome 5. Severe Anxiety (Short Term) 6. Pain And Restlessness For Palliative Care
  • 44. • Antipsychotics are conventionally used for the management of schizophrenia. • Schizophrenia is a psychotic disorder that affects 1 % of the population, making it the most common psychotic disorder. • It causes positive symptoms, such as delusions, hallucinations and thought disorder, and negative symptoms, including social withdrawal and a flattened affect. • Longer-acting depot formulations of antipsychotic drugs are also available and may be used in cases of patient preference or if compliance is a problem.
  • 45. • It should be noted that not all patients with schizophrenia respond to therapy with antipsychotic agents. • In patients who are resistant to two or more different antipsychotic agents, clozapine is recommended, given its potency. • However, because of its potentially dangerous side effects, including leukopenia, agranulocytosis, and Myocarditis, it is usually reserved for resistant cases. • It requires close monitoring when used, with weekly blood tests in the first 6 months of use. • About 30 % of patients have treatment-resistant schizophrenia, which means that they are resistant to all available antipsychotics.
  • 47. Drug-Induced Dyskinesia Motor side effect Description Management Acute dystonia Spasms of the facial or neck muscles. Occurs within the first few weeks of commencing an antipsychotic drug. Generally decreases over time. Improves when the drug is ceased. May be treated with an anticholinergic. Akathisia Psychomotor restlessness. Improves when the drug is ceased. May be treated with an anticholinergic.
  • 48. Parkinsonianism Bradykinesia, tremor, rigidity and shuffling gait. Improves when the drug is ceased. May be treated with an anticholinergic. Tardive dyskinesia A serious and potentially disabling condition. Involuntary movements of the face, tongue, trunk, and limbs. This occurs after months or years of starting a first-generation antipsychotic drug, affecting 20—40 % of patients. More common in patients over the age of 50. It does not improve when the drug is ceased. Usually irreversible.